Published in Clin Sci (Lond) on December 01, 1980
Circulating and tissue angiotensin systems. J Clin Invest (1987) 2.16
Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest (1986) 1.73
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res (1992) 3.95
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem (1991) 3.22
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A (1988) 3.21
The number needed to treat: a clinically useful nomogram in its proper context. BMJ (1996) 2.89
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41
Direct evidence for chromosomal inversion during T-cell receptor beta-gene rearrangements. Nature (1986) 2.33
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet (2001) 2.28
Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology (2000) 2.28
Clonal analysis of B- and T-cell responses to Ia antigens. I. Topology of epitope regions on I-Ak and I-Ek molecules analyzed with 35 monoclonal alloantibodies. Immunogenetics (1981) 2.27
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest (1996) 2.20
New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet (1996) 2.20
Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology (1972) 2.13
The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol (2000) 2.04
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (1988) 1.91
The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem (1991) 1.86
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Typing prion isoforms. Nature (1997) 1.82
Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem (1991) 1.65
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol (1997) 1.65
Do physicians estimate reliably the cardiovascular risk of hypertensive patients?. Medinfo (1995) 1.62
Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res (1983) 1.62
The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem (1995) 1.58
Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol (1986) 1.55
Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55
Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab (1997) 1.52
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem (2001) 1.51
Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem (1996) 1.49
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest (1997) 1.48
Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes. Nat Biotechnol (1997) 1.47
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health. Proc Natl Acad Sci U S A (2001) 1.46
Multiple forms of human renin. Purification and characterization. J Biol Chem (1979) 1.45
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43
Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. J Am Coll Cardiol (1990) 1.43
The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem (1992) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barré syndrome. Neurology (2005) 1.41
Maturation-dependent changes of angiotensin receptor expression in fowl. Am J Physiol Regul Integr Comp Physiol (2003) 1.41
Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res (2005) 1.39
Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. J Urol (1995) 1.39
Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines? J Hypertens (1999) 1.38
Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension (1994) 1.38
Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Biol Chem (1998) 1.38
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J Biol Chem (1994) 1.35
Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension (1997) 1.31
Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension (1993) 1.29
Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol (2001) 1.28
Molecular cloning of genes encoding branched-chain keto acid dehydrogenase of Pseudomonas putida. J Bacteriol (1987) 1.28
Structure of human angiotensinogen gene. DNA (1989) 1.28
Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav (1993) 1.28
Benefits of a computer-assisted education program for hypertensive patients compared with standard education tools. Patient Educ Couns (1995) 1.27
Three cases of canine leptospirosis in Quebec. Can Vet J (1999) 1.26
Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Virology (2000) 1.26
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A (1996) 1.26
Species distribution of testosterone-binding globulin. Biol Reprod (1973) 1.26
Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein. Virology (1999) 1.25
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet (1997) 1.24
Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension (1994) 1.24
Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med (1991) 1.23
Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet (1997) 1.23
CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter. J Virol (1998) 1.23
Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol (1996) 1.22
The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett (1989) 1.22
An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO J (1993) 1.22
Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab (1982) 1.22
Role of angiotensinogen in blood pressure homeostasis. Hypertension (1982) 1.21
A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem (1995) 1.19
Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension (1996) 1.18
Mechanism of renin release following furosemide diuresis in rabbit. Am J Physiol (1968) 1.17
Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling. J Virol (2001) 1.17
Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology (2000) 1.16
Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol (2000) 1.16
Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci U S A (1988) 1.16
Use of a specific antiserum for renin detection in human kidney. J Histochem Cytochem (1980) 1.15
Molecular cloning of a mouse submaxillary gland renin cDNA fragment. Proc Natl Acad Sci U S A (1981) 1.15
Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J Biol Chem (1996) 1.15
The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO J (1994) 1.14
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia (2013) 1.14
Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4). Mol Cell Biol (2000) 1.13
Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol (1997) 1.13
Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest (2000) 1.12
Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry (1986) 1.12
Effects of induced hyperthyroidism on steroid metabolism in man. J Clin Endocrinol Metab (1971) 1.12
Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France. Aliment Pharmacol Ther (1996) 1.11